Krystyna Łoboz-Grudzień

Krystyna Łoboz-Grudzień

Auto-generated profile, based on publicly available information

Krystyna Łoboz-Grudzień

Department of Cardiology, Marciniak Lower Silesian Specialist Hospital-Emergency Medicine Center, Wroc?aw, Poland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
Izabella UchmanowiczIzabella Uchmanowicz
Izabella Uchmanowicz
BJBeata Jankowska-Polanska
Beata Jankowska-Polanska
KDKrzysztof Dudek
Krzysztof Dudek
KŁKrystyna łoboz-Grudzień
Krystyna łoboz-Grudzień
Background: The aims of this study were to analyze the dynamics of quality of life (QoL) changes after 36 months from the percutaneous coronary intervention (PCI) depending on sex and identify baseline predictors of the follow-up QoL of patients hospitalized for acute coronary syndrome (ACS) and subjected to PCI. Methods and results: The study included 137 patients, females (n=67) and males (n=70), with ACS who underwent PCI. The QoL was assessed using the MacNew Heart Disease Health-Related Quality of Life questionnaire. The group of females scored lower in all the domains of the MacNew Heart Disease Health-Related Quality of Life questionnaire in the initial measurement (B1), in the measurement after 6 months (B2), and in the long-term follow-up measurement (36 months – B3). Despite the fact that both groups achieved improved QoL, its values were higher in the males. The average growth rate of the QoL score in the period from the sixth month to 36th month was higher in females than in males. In the univariate and multivariate analyses, significant independent predictors with a negative influence on the long-term QoL score included female sex (Ρ=−0.190, β=−0.21), age >60 years (Ρ=−0.255, β=−0.186), and diabetes (Ρ=−0.216, β=−0.216). Conclusion: In a 36-month follow-up of ACS patients treated with PCI, there were no statistically significant differences in QoL between sexes. In the entire cohort, there was improvement in QoL, which was higher in the case of the females studied. For the entire group, significant independent determinants of lower QoL 3 years after ACS included female sex, age >60 years, and diabetes.

5 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
RWRadosław Wontor
Radosław Wontor
MLMagdalena Lisiak
Magdalena Lisiak
MŁMaria Łoboz-Rudnicka
Maria Łoboz-Rudnicka
BOBogusława Ołpińska
Bogusława Ołpińska
RWRafał Wyderka
Rafał Wyderka
JJJoanna Jaroch
Joanna Jaroch
Background/Objectives: The ageing population has heightened interest in the prognostic role of geriatric conditions, notably frailty syndrome (FS) and cognitive impairment (CI). Evidence indicates a significant link between cardiovascular disease, FS, and CI. However, limited research has explored the impact of impaired functional and cognitive performance on outcomes in acute coronary syndrome (ACS) patients. This study aimed to evaluate the effect of coexisting FS and CI (FSxCI) on early and 6-month complications in older adults with ACS. Methods: This study included 196 ACS patients (119 men) aged 65 and over (mean = 74.7 years), with 90.8% undergoing invasive treatment (PCI in 81.6%, CABG in 9.2%). FS and CI were assessed on the third hospital day using the Tilburg Frailty Indicator (TFI) and Mini Mental State Examination (MMSE). Early (in-hospital) complications included major bleeding, ventricular arrhythmia (VT), conduction disturbances, cardiac arrest, stent thrombosis, acute heart failure (Killip–Kimball class III/IV), stroke, prolonged stay, and in-hospital death. Six-month follow-up recorded major adverse cardiovascular and cerebrovascular events (MACCEs). Results: Patients with FSxCI (n = 107, 54.6%) were older and had higher hypertension prevalence and lower nicotine dependence. FSxCI patients faced over twice the risk of prolonged hospital stays (OR 2.39; p = 0.01) and nearly three times the risk of early complications (OR 2.73; p < 0.001). At 6 months, FSxCI tripled the risk of MACCEs (OR 2.8; p = 0.007). Kaplan–Meier analysis confirmed a worse 6-month prognosis for FSxCI patients. Conclusions: Elderly patients with ACS and concomitant FSxCI had significantly higher rates of early (in-hospital) and 6-month complications. FSxCI was associated with a worse 6-month prognosis. This highlights its significance for clinical decision-making, as identifying FSxCI in ACS patients can help prioritize high-risk individuals for tailored interventions, optimize resource allocation, and improve outcomes.

1 October 2007
Verified
Journal Article
Closed access
BBBarbara Brzezińska
Barbara Brzezińska
KLKrystyna Loboz-Grudzień
Krystyna Loboz-Grudzień
LSLeszek Sokalski
Leszek Sokalski

KLKatarzyna Lomper
Katarzyna Lomper
MŁMaria Łoboz-Rudnicka
Maria Łoboz-Rudnicka
TBTomasz Bańkowski
Tomasz Bańkowski
KŁKrystyna Łoboz-Grudzień
Krystyna Łoboz-Grudzień
JJJoanna Jaroch
Joanna Jaroch
Background: The impact of frailty syndrome (FS) and dementia on the convenience and satisfaction with oral anticoagulation (OAC) treatment in atrial fibrillation (AF) patients is not well-known. Aim: Assessment the impact of FS and dementia on the convenience and satisfaction with OAC treatment in 116 elderly (mean age 75.2, SD = 8.2) patients with AF. Methodology: A self-administered questionnaire was used in the study to collect basic socio-demographic and clinical data. Tilburg Frailty Indicator (TFI) questionnaire was used to assess the presence of FS, Mini Mental State Examination (MMSE) to assess cognitive impairment (CI), The Perception of Anticoagulant Treatment Questionnaire Part 2 (PACT-Q2) to assess convenience and satisfaction with OAC treatment, and the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA) to assess quality of life (QoL). Results: Multivariable analysis as a significant, negative predictor of the convenience and satisfaction domain showed the occurrence of dementia (β = −0.34; p < 0.001, β = −0.41; p < 0.001, respectively) and prior major bleeding (β = −0.30; p < 0.001, β = −0.33; p < 0.001, respectively). Analysis showed a significant relationship between convenience and satisfaction and the overall result of the ASTA (r = −0.329; p < 0.001, r = −0.372; p < 0.001, respectively). Conclusions: Elements of geriatric syndrome, such as FS and dementia, adversely affect treatment convenience and satisfaction with OAC treatment in AF. It has been shown that better convenience and satisfaction with OAC treatment translates into better QoL. There were no differences between satisfaction and convenience and the type of OAC treatment (vitamin K antagonists (VKA) vs. novel oral anticoagulants (NOAC).

1 March 2024 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
BOBogusława Ołpińska
Bogusława Ołpińska
RWRafał Wyderka
Rafał Wyderka
MŁMaria Łoboz-Rudnicka
Maria Łoboz-Rudnicka
BBBarbara Brzezińska
Barbara Brzezińska
KŁKrystyna Łoboz-Grudzień
Krystyna Łoboz-Grudzień
JJJoanna Jaroch
Joanna Jaroch
Background: Little is known about the effect of cardiac rehabilitation (CR) on carotid arterial stiffness (CAS) in patients with myocardial infarction (MI). Patients and Methods: Rehabilitation group (B) included 90 patients with MI subjected to CR, control group (K) consisted of 30 patients with MI not participating in CR, and healthy group comprised 38 persons without cardiovascular risk factors. CAS was determined using echo-tracking before and after CR. Results: At baseline, patients with MI (B+K) presented with significantly higher mean values of CAS parameters: beta-stiffness index (7.1 vs 6.4, p = 0.004), Peterson’s elastic modulus (96 kPa vs 77 kPa, p < 0.001) and PWV-beta (6.1 m/s vs 5.2 m/s, p < 0.001) than healthy persons. Age (beta: r = 0.242, p = 0.008; EP: r = 0.250, p = 0.006; PWV-beta: r = 0.224, p = 0.014) and blood pressure: SBP (EP: r = 0.388, PWV-beta: r = 0.360), DBP (AC: r = 0.225) and PP (PWV-beta: r = 0.221) correlated positively with the initial parameters of CAS. Beta-stiffness index (Rho=− 0.26, p = 0.04) and PWV-beta (Rho = 0.29, p = 0.03) correlated inversely with peak exercise capacity expressed in METs. After CR, mean values of beta-stiffness index (6.2 vs 7.1, p = 0.016), EP (78 kPa vs 101 kPa, p = 0.001) and PWV-beta (5.4 m/s vs 6.2 m/s, p = 0.001) in group B were significantly lower than in group K. In group B, CAS parameters decreased significantly after CR. Univariate analysis demonstrated that the likelihood of an improvement in CAS after CR was significantly higher in patients with baseline systolic blood pressure < 120 mm Hg (OR = 2.74, p = 0.009) and left ventricular ejection fraction < 43% (OR = 5.05, p = 0.005). Conclusion: In patients with MI, CR exerted a beneficial effect on CAS parameters. The improvement in CAS was predicted by lower SBP and LVEF at baseline.

15 June 2026 in Medical Science Monitor
Verified
Journal Article
Open access
RWRadosław Wontor
Radosław Wontor
MŁMaria Łoboz-Rudnicka
Maria Łoboz-Rudnicka
BOBogusława Ołpińska
Bogusława Ołpińska
KDKrzysztof Dudek
Krzysztof Dudek
MLMagdalena Lisiak
Magdalena Lisiak
JJJoanna Jaroch
Joanna Jaroch
With an aging population, there is a growing proportion of patients with frailty and acute coronary syndrome (ACS). However, there is a paucity of data on optimal management and risk stratification. We aimed to assess the impact of frailty on early and midterm adverse events in patients with ACS. This was a prospective, observational study including 196 patients aged 65 years or older (mean age 74.4 years) with ACS. Frailty was assessed with the Tilburg Frailty Indicator (TFI). Patients were classified as non-frail (TFI score 0–4), with mild frailty (TFI score 5–8 points), and with moderate/severe frailty (TFI >8 points). In-hospital complications and major cardiovascular and cerebrovascular events (MACCEs) at 6-month follow-up were analyzed. The rate of overall in-hospital complications and prolonged length of stay was increased in frail patients vs non-frail (61.3% vs 25.4%; P<0.001; and 54% vs 16.9%; P<0.001). At 6-month follow-up, MACCEs were observed more often in patients with moderate/severe frailty (22.2% vs 5.1%; P=0.019), and all-cause death more often in patients with frailty vs non-frail (10.9% vs 1.7%; P=0.03). Elevated TFI score was an independent predictor of in-hospital and midterm MACCEs in patients with ACS (TFI ≥5 points for in-hospital, and ≥8 points for midterm complications). Frailty syndrome is associated with impaired early and midterm outcomes in older adult patients with ACS, independent of chronological age. Assessment of frailty in patients with ACS provides data valuable for risk stratification and management.